Roger Prades, Iproteos CSO, will be attending the 28th ECNP Congress of Applied and Translational Neuroscience, which will take place in Amsterdam from the 29th of August till the 1st of September. The good news is that his poster has been selected for a short oral presentation, since his abstract is among the 18 with the highest score. Taking into account that in the previous ECNP Congress, which was held on Berlin, there were more than 5,500 attendees, it is an honor for Iproteos to have been selected for the oral presentation. The European College of Neuropsychopharmacology was established in 1987. Since then, it organizes an annual congress and other meetings and workshops as well, gathering together scientists in order to facilitate exchange in the convergent disciplines of nneuropsychopharmacology.